Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Healthtrust
Moodys
Covington
Accenture
US Department of Justice
Fuji
Boehringer Ingelheim
Harvard Business School
Deloitte

Generated: October 18, 2017

DrugPatentWatch Database Preview

OPTIRAY 240 Drug Profile

« Back to Dashboard

What is the patent landscape for Optiray 240, and what generic Optiray 240 alternatives are available?

Optiray 240 is a drug marketed by Liebel-flarsheim and is included in two NDAs.

The generic ingredient in OPTIRAY 240 is ioversol. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ioversol profile page.

Summary for Tradename: OPTIRAY 240

US Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list28
Clinical Trials: see list692
Patent Applications: see list735
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OPTIRAY 240 at DailyMed

Pharmacology for Tradename: OPTIRAY 240

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Liebel-flarsheim
OPTIRAY 240
ioversol
INJECTABLE;INJECTION019710-002Dec 30, 1988RXYesYes► Subscribe► Subscribe► Subscribe
Liebel-flarsheim
OPTIRAY 240
ioversol
INJECTABLE;INJECTION020923-001May 28, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: OPTIRAY 240

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Liebel-flarsheim
OPTIRAY 240
ioversol
INJECTABLE;INJECTION019710-002Dec 30, 1988► Subscribe► Subscribe
Liebel-flarsheim
OPTIRAY 240
ioversol
INJECTABLE;INJECTION020923-001May 28, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Argus Health
Citi
Cipla
Colorcon
UBS
Johnson and Johnson
Fish and Richardson
Farmers Insurance
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot